Cytokinetics (CYTK) PT Raised to $63 at Raymond James
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $74.13 --0%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 14
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 14
Join SI Premium – FREE
Raymond James analyst Dane Leone raised the price target on Cytokinetics (NASDAQ: CYTK) to $63.00 (from $54.00) while maintaining a Outperform rating.
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
- Allianz SE (ALV:GR) (AZSEY) PT Raised to EUR460 at JPMorgan
- JPMorgan Downgrades Amcor Plc. (AMCR) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
